Angiozyme
Term · Oncology and biomedicine · MLC-T-ONC-000549
A substance being studied in the treatment of cancer. Angiozyme is a special type of RNA made in the laboratory. It stops a protein called vascular endothelial growth factor receptor (VEGFR) from being made. This may prevent the growth of new blood vessels that tumors need to grow. It is a type of angiogenesis inhibitor and a type of ribozyme. Also called RPI.4610.
| Identifier | MLC-T-ONC-000549 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | RPI.4610 |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000549",
"term": "Angiozyme",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of cancer. Angiozyme is a special type of RNA made in the laboratory. It stops a protein called vascular endothelial growth factor receptor (VEGFR) from being made. This may prevent the growth of new blood vessels that tumors need to grow. It is a type of angiogenesis inhibitor and a type of ribozyme. Also called RPI.4610.",
"synonyms": [
"RPI.4610"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/angiozyme/"
}
Record 1,128 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.